1. Home
  2. OGN vs BATRA Comparison

OGN vs BATRA Comparison

Compare OGN & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • BATRA
  • Stock Information
  • Founded
  • OGN 1923
  • BATRA 1991
  • Country
  • OGN United States
  • BATRA United States
  • Employees
  • OGN N/A
  • BATRA N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • BATRA Broadcasting
  • Sector
  • OGN Health Care
  • BATRA Industrials
  • Exchange
  • OGN Nasdaq
  • BATRA Nasdaq
  • Market Cap
  • OGN 2.7B
  • BATRA 2.9B
  • IPO Year
  • OGN N/A
  • BATRA N/A
  • Fundamental
  • Price
  • OGN $6.66
  • BATRA $42.44
  • Analyst Decision
  • OGN Buy
  • BATRA Strong Buy
  • Analyst Count
  • OGN 3
  • BATRA 3
  • Target Price
  • OGN $17.33
  • BATRA $58.00
  • AVG Volume (30 Days)
  • OGN 6.0M
  • BATRA 47.2K
  • Earning Date
  • OGN 10-30-2025
  • BATRA 11-05-2025
  • Dividend Yield
  • OGN 1.20%
  • BATRA N/A
  • EPS Growth
  • OGN N/A
  • BATRA N/A
  • EPS
  • OGN 2.69
  • BATRA N/A
  • Revenue
  • OGN $6,281,000,000.00
  • BATRA $702,443,000.00
  • Revenue This Year
  • OGN N/A
  • BATRA $14.16
  • Revenue Next Year
  • OGN $0.65
  • BATRA $3.97
  • P/E Ratio
  • OGN $2.48
  • BATRA N/A
  • Revenue Growth
  • OGN N/A
  • BATRA 6.51
  • 52 Week Low
  • OGN $6.39
  • BATRA $38.67
  • 52 Week High
  • OGN $19.05
  • BATRA $50.50
  • Technical
  • Relative Strength Index (RSI)
  • OGN 16.88
  • BATRA 26.44
  • Support Level
  • OGN $8.87
  • BATRA $41.97
  • Resistance Level
  • OGN $9.28
  • BATRA $43.49
  • Average True Range (ATR)
  • OGN 0.35
  • BATRA 0.68
  • MACD
  • OGN -0.30
  • BATRA -0.00
  • Stochastic Oscillator
  • OGN 6.84
  • BATRA 23.00

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: